Cardiac Hypertrophy: A Review on Pathogenesis and Treatment

REVIEW Open Access Cardiac hypertrophy in chronic kidney disease—role of Aldosterone and FGF23 Koichi Hayashi1*, Toshihiko Suzuki2, Yusuke Sakamaki1 and Shinsuke Ito2 Abstract Cardiac hypertrophy is a life-threatening disorder and is frequently observed in patients with chronic kidney disease ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download